Home › NDC Lookup › Ingredients › Simethicone › 00536-1223-08
Rugby Gas relief Simethicone 125 mg Tablet, Chewable, 60-count — NDC 00536-1223-08 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Rugby Gas relief Simethicone 125 mg Tablet, Chewable, 60-count — NDC 0536-1223-08 (Billing 00536-1223-08)

by Rugby Laboratories · 60 TABLET, CHEWABLE in 1 BOTTLE

This is a package of 60 tablets of Rugby Gas relief Simethicone 125 mg Tablet, Chewable from Rugby Laboratories, marketed since Apr 2019 and currently FDA-listed; retail pharmacies pay about $0.1028 per tablet (NADAC). It is this product's only package size.

NDC 00536-1223-08
🏷️ FDA NDC (as labeled) 0536-1223-08 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1223-08
Product NDC 0536-1223
11-digit billing NDC 00536122308
NCPDP billing unit EA — each (per item)
RxCUI 314221
UNII 92RU3N3Y1O
UPC 0305361223083
Application # M016
SPL Set ID 9b84f74f-8609-489d-b411-3103afa1b5c2
Physiologic effect Skin Barrier Activity
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-04-29
Route ORAL
Dosage form TABLET, CHEWABLE
Substance DIMETHICONE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 52200020000530
GPI class Gas Relief Extra Strength
GCN Seq No 002819
GCN 08282
HICL code 001224
Ingredient (HICL) Simethicone
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4N
Therapeutic class — specific (HIC3) Antiflatulents
AHFS code 56:10.00.00
AHFS class Antiflatulents
FDB label name GAS RELIEF 125 MG CHEW TABLET
FDB brand name Gas Relief
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002819
  • GCN: 08282
  • GPI-14 (Medi-Span): 52200020000530
  • HICL (First Databank): 001224
  • AHFS class code: 56:10.00.00
  • RxCUI (RxNorm): 314221
Why two NDCs? The FDA registers this code as 0536-1223-08 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1223-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name GAS RELIEF 125 MG CHEW TABLET Ingredient Simethicone
📗 Our plain-language guide HelloPharmacist
  • It relieves the discomfort of gas. For adults, that means pressure, bloating and fullness. Infant drops are for baby gas, often caused by swallowed air or certain formulas or foods...
  • Shake the bottle well. Use only the syringe or dropper that came with it. Dispense it slowly toward the inner cheek. You can also mix it with 1 oz. of cool water, formula or anothe...
  • Doses can be repeated as needed after meals and at bedtime. Do not go over 12 doses in a day. Follow your product’s label and your doctor’s advice.
  • If you can, use your child’s weight. If not, use age. Check the chart on your product, and ask me or your doctor if you are unsure.
📖 Read our full Simethicone guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.103 $6.17 / 60 tablets
Medicaid paysCMS SDUD · 12 mo $0.1392 $8.35 / 60 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Aug 2022 Jan 2026 Sep 2026 $0.110 $0.096
▼ Down 3% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00536-1223-08 You're viewing this Main listing 60 TABLET, CHEWABLE in 1 BOTTLE 2019-04-29 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
gas relief 125 mg 62011-0189-01 Strategic 9 tablets $0.097 — FDA listed save 6%
Rugby Gas relief 125 mgthis 00536-1223-08 Rugby 60 tablets $0.103 — Availability likely —
extra strength Gas Relief cherry creme 125 mg 46122-0811-08 Amerisource 9 tablets $0.103 — Availability likely —
Foster and Thrive Extra Strength Gas Relief Cherry 125 mg 70677-1077-01 Strategic 9 tablets $0.103 — Availability likely —
Gas-X Extra Strength 125 mg 00067-0117-01 Haleon 12 tablets — — FDA listed —
Gas-X Extra Strength 125 mg 00067-0129-18 Haleon 9 tablets — — FDA listed —
Walgreens Extra Strength 125 mg 00363-0118-18 WALGREENS 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 00363-0119-18 WALGREENS 9 tablets — — FDA listed —
Gas Relief - Cherry Flavor 125 mg 11673-0066-48 TARGET 12 tablets — — FDA listed —
up and up extra strength gas relief chewables Extra Strength 125 mg 11673-0610-48 Target 12 tablets — — FDA listed —
Gas Relief 125 mg 11822-6080-02 Rite 12 tablets — — FDA listed —
Simethicone 125 mg 17714-0040-60 Advance 60 tablets — — FDA listed —
Simethicone 125 mg 17856-0137-01 ATLANTIC 1 tablet — — FDA listed —
Extra Strength Gas Relief 125 mg 21130-0110-18 SAFEWAY 6 tablets — — FDA listed —
Gas Relief 125 mg 21130-0135-73 Safeway 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 21130-0441-18 SAFEWAY 9 tablets — — FDA listed —
Kroger Extra Strength Gas Relief 125 mg 30142-0481-48 KROGER 4 tablets — — FDA listed —
Gas Relief 125 mg 36800-0122-73 Topco 6 tablets — — FDA listed —
TopCare Extra Strength Gas Relief Cherry Creme 125 mg 36800-0488-48 TOPCO 48 tablets — — FDA listed —
HEB Gas Relief Extra Strength Peppermint 125 mg 37808-0155-73 H 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 37808-0692-13 H 12 tablets — — FDA listed —
Extra Strength Simethicone 125 mg 37835-0233-18 Bi-Mart 9 tablets — — FDA listed —
gas relief 125 mg 41163-0408-44 United 9 tablets — — FDA listed —
Extra Strength gas relief 125 mg 41415-0110-18 PUBLIX 6 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 42507-0701-34 Hyvee 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 49035-0910-48 Wal-Mart 48 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 50804-0134-73 Good 9 tablets — — FDA listed —
CVS PHARMACY Extra Strength Gas Relief 125 mg 51316-0011-18 CVS 9 tablets — — FDA listed —
CVS PHARMACY Extra Strength 125 mg 51316-0110-18 CVS 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry Creme 125 mg 51316-0134-13 CVS 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry Flavor 125 mg 53943-0134-39 Discount 9 tablets — — FDA listed —
Gas Relief Extra Strength 125 mg 55301-0680-44 ARMY 9 tablets — — FDA listed —
Family Wellness Extra Strength Gas Relief Cherry 125 mg 55319-0134-34 Family 12 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 57896-0694-03 Geri-Care 30 tablets — — FDA listed —
Mylanta Gas Minis Mint Flavor 125 mg 62372-0800-50 Infirst 50 tablets — — FDA listed —
Mylanta Gas Minis Assorted Fruit Flavor 125 mg 62372-0801-03 Infirst 3 tablets — — Discontinued —
Best Choice Extra Strength 125 mg 63941-0110-18 BEST 9 tablets — — FDA listed —
WinCo FOODS Extra Strength Gas Relief 125 mg 67091-0361-18 WINCO 6 tablets — — FDA listed —
Premier Value Extra Strength 125 mg 68016-0811-18 PHARMACY 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 69256-0134-73 Harris 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 69256-0135-73 Harris 9 tablets — — FDA listed —
Simethicone 125 mg 69618-0032-06 Reliable 60 tablets — — FDA listed —
Gas-Aid 125 mg 69626-7197-03 Leosons 9 tablets — — FDA listed —
Firstcare Gas Relief Simethicone 125 mg Anti-gas 71594-0709-10 USpharma 100 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 72476-0134-73 Retail 9 tablets — — FDA listed —
Gas Relief 125 mg 79481-0608-04 Meijer 9 tablets — — FDA listed —
Gas Relief 125 mg 80136-0859-68 Heartland 100 tablets — — FDA listed —
Wonderbelly Extra Strength Anti-Gas 125 mg 82431-0201-02 Ginger 2 tablets — — Discontinued —
Wonderbelly Extra Strength Anti-Gas 125 mg 82431-0202-02 Ginger 2 tablets — — Discontinued —
Wonderbelly Extra Strength Anti-Gas 125 mg 82431-0203-02 Ginger 2 tablets — — Discontinued —
Wonderbelly Extra Strength Anti-Gas 82431-0291-10 Ginger 10 tablets — — Discontinued —
Simethicone 125 mg 82804-0152-09 Proficient 9 tablets — — FDA listed —
QCH Extra Strength Gas Relief Cherry Flavor 134CHR 125 mg 83324-0132-18 Chain 9 tablets — — FDA listed —
Gas Relief 125 mg 83324-0325-18 Chain 9 tablets — — FDA listed —
Pepto Gas plus Bloating 125 mg 84126-0378-16 The 16 tablets — — FDA listed —
Maximum Strength Antacid Mint 125 mg 53041-0100-23 Guardian 60 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Apr 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeRound
ImprintGDC131
Size16 mm
ScoringNot scored
FlavorPeppermint
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 81H2R5AOH3
    A natural sweetener and carbohydrate derived from sugarcane plants. In medicines, it sweetens the taste to improve palatability and may serve as a bulking agent or binder in tablets and powders.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescompressible sugar, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRugby Laboratories
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedApr 2019
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 9 words ▾

USE(S) relieves: pressure bloating symptoms referred to as gas

⏱️ Dosage and Administration 33 words ▾

DIRECTIONS chew 1 to 2 tablets thoroughly as needed after meals and at bedtime do not exceed 4 tablets in a 24 hour period except under the advice and supervision of a physician

⚠️ Warnings 2 words ▾

WARNINGS .

📦 Storage and Handling 27 words ▾

OTHER INFORMATION do not use if inner seal is broken store at room temperature avoid high humidity and excessive heat, above 40 o C (104 o F)

🧪 Active Ingredient 7 words ▾

ACTIVE INGREDIENT(in each tablet) Simethicone 125 mg

🧪 Inactive Ingredients 12 words ▾

INACTIVE INGREDIENTS compressible sugar, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol.

🎯 Purpose 2 words ▾

PURPOSE Anti-gas

📄 Keep Out of Reach of Children 27 words ▾

KEEP OUT OF REACH OF CHILDREN Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.

📄 Questions or Comments 6 words ▾

QUESTIONS OR COMMENTS? 1 (800) 645-2158

📄 Package Label / Principal Display Panel 35 words ▾

PRINCIPAL DISPLAY PANEL NDC 0536-1223-08 compare to active ingredient in gas-x ® Extra strength* Rugby extra strength gas relief Simethicone 125 mg each antigas mint flavor relieves gas pain pressure boating 60 CHEWABLE TABLETS 131-60-rugby.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
22.8K
Units reimbursed last 4 qtrs
1.5M
Gross reimbursed last 4 qtrs
$210.5K
Avg / prescription
$9.22
Avg / unit
$0.1392
Latest quarter Q1 2026
5.5KRx
Medicaid pays / ea
$0.1392
gross reimbursed
vs
NADAC / ea
$0.1028
acquisition cost
=
Spread
+$0.0364
+35% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
29% FFS 71% MCO
Fee-for-service · 6,568 Rx Managed care · 16,265 Rx
State Medicaid map
Alaska: no data reported AK Maine: 37,498 units · 2,688 per 100k residents ME Washington: 75,016 units · 960 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 185,333 units · 3,230 per 100k residents MN Wisconsin: no data reported WI Michigan: 196,018 units · 1,953 per 100k residents MI New York: 43,283 units · 221 per 100k residents NY Vermont: 2,605 units · 403 per 100k residents VT New Hampshire: no data reported NH Oregon: 13,398 units · 317 per 100k residents OR Nevada: 10,650 units · 333 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 14,159 units · 113 per 100k residents IL Indiana: 31,798 units · 463 per 100k residents IN Ohio: 144,855 units · 1,229 per 100k residents OH Pennsylvania: 115,005 units · 887 per 100k residents PA New Jersey: 70,601 units · 760 per 100k residents NJ Massachusetts: 162,008 units · 2,314 per 100k residents MA California: 38,982 units · 100 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 41,616 units · 2,104 per 100k residents NE Missouri: no data reported MO Kentucky: 150,917 units · 3,334 per 100k residents KY West Virginia: no data reported WV Virginia: 21,515 units · 247 per 100k residents VA Maryland: 7,941 units · 128 per 100k residents MD Connecticut: no data reported CT Rhode Island: 4,617 units · 422 per 100k residents RI Arizona: 34,041 units · 458 per 100k residents AZ New Mexico: 1,917 units · 90.7 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: 18,547 units · 1,799 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: 664 units · 97.8 per 100k residents DC Hawaii: 9,924 units · 692 per 100k residents HI Texas: 79,020 units · 259 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
90.73,334
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 3,334 /100k
2 Minnesota 3,230 /100k
3 Maine 2,688 /100k
4 Massachusetts 2,314 /100k
5 Nebraska 2,104 /100k
6 Michigan 1,953 /100k
7 Delaware 1,799 /100k
8 Ohio 1,229 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Rugby Gas relief (this brand).

Top reported reactions

Nausea106
Fatigue83
Diarrhoea79
Vomiting70
Abdominal Pain67
Dyspnoea66
Pain58

Age at onset

Neonate2
Infant1
Child9
Adolescent6
Adult27
Elderly11

Reporter sex

1,061 reports
Male · 49%
Female · 51%
Unknown · 0%

Serious outcomes

Hospitalization565
Death150
Disabling29
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 9 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 00536-1214-29 · Rugby 00536-1224-97 · Rugby →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.